- Credit Suisse's 26th Annual Healthcare Conference on November 7 in Scottsdale, AZ
- Stifel 2017 Healthcare Conference on November 14 in New York
- Evercore ISI Biopharma Catalyst/Deep Dive Conference on November 29 in Boston
Oct 31, 2017
SAN RAFAEL, Calif., Oct. 31, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in Credit Suisse's 26th Annual Healthcare Conference on November 7, 2017 at 9:10am MT/11:10am ET, in Scottsdale, Arizona, the Stifel 2017 Healthcare Conference on November 14, 2017 at 10:15am ET in New York and the Evercore ISI Biopharma Catalyst/Deep Dive Conference on November 29, 2017 at 11:00am ET in Boston. To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
|
Contacts:
|
|
Investors
|
Media
|
|
Traci McCarty
|
Debra Charlesworth
|
|
BioMarin Pharmaceutical Inc.
|
BioMarin Pharmaceutical Inc.
|
|
(415) 455-7558
|
(415) 455-7451
|
SOURCE BioMarin Pharmaceutical Inc.